We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cardlytics, Inc. (CDLX) Hits 52-Week High, Can the Run Continue?
Read MoreHide Full Article
Have you been paying attention to shares of Cardlytics (CDLX - Free Report) ? Shares have been on the move with the stock up 18.1% over the past month. The stock hit a new 52-week high of $30.38 in the previous session. Cardlytics has gained 172.4% since the start of the year compared to the 31.2% move for the Zacks Business Services sector and the 24% return for the Zacks Technology Services industry.
What's Driving the Outperformance?
The stock has a great record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last four quarters. In its last earnings report on May 9, 2019, Cardlytics, Inc. reported EPS of $-0.23 versus consensus estimate of $-0.37 while it missed the consensus revenue estimate by 0.02%.
For the current fiscal year, Cardlytics, Inc. is expected to post earnings of $-0.6 per share on $186.97 million in revenues. This represents a 17.81% change in EPS on a 24.08% change in revenues. For the next fiscal year, the company is expected to earn $0.19 per share on $258.93 million in revenues. This represents a year-over-year change of 133% and 38.49%, respectively.
Valuation Metrics
Cardlytics, Inc. may be at a 52-week high right now, but what might the future hold for the stock? A key aspect of this question is taking a look at valuation metrics in order to determine if the company has run ahead of itself.
On this front, we can look at the Zacks Style Scores, as these give investors a variety of ways to comb through stocks (beyond looking at the Zacks Rank of a security). These styles are represented by grades running from A to F in the categories of Value, Growth, and Momentum, while there is a combined VGM Score as well. The idea behind the style scores is to help investors pick the most appropriate Zacks Rank stocks based on their individual investment style.
Cardlytics, Inc. has a Value Score of F. The stock's Growth and Momentum Scores are A and A, respectively, giving the company a VGM Score of B.
Zacks Rank
We also need to look at the Zacks Rank for the stock, as this supersedes any trend on the style score front. Fortunately, Cardlytics, Inc. currently has a Zacks Rank of #2 (Buy) thanks to favorable earnings estimate revisions from covering analysts.
Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Cardlytics, Inc. passes the test. Thus, it seems as though Cardlytics, Inc. shares could have a bit more room to run in the near term.
How Does Cardlytics, Inc. Stack Up to the Competition?
Shares of Cardlytics, Inc. have been moving higher, and the company still appears to be a decent choice, but what about the rest of the industry? Some of its industry peers are also solid potential picks, including Jianpu Technology , Smiths Group (SMGZY - Free Report) , and TeleTech Holdings (TTEC - Free Report) , all of which currently have a Zacks Rank of at least #2 and a VGM Score of at least B, making them well-rounded choices.
The Zacks Industry Rank is in the top 39% of all the industries we have in our universe, so it looks like there are some nice tailwinds for Cardlytics, Inc.even beyond its own solid fundamental situation.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Cardlytics, Inc. (CDLX) Hits 52-Week High, Can the Run Continue?
Have you been paying attention to shares of Cardlytics (CDLX - Free Report) ? Shares have been on the move with the stock up 18.1% over the past month. The stock hit a new 52-week high of $30.38 in the previous session. Cardlytics has gained 172.4% since the start of the year compared to the 31.2% move for the Zacks Business Services sector and the 24% return for the Zacks Technology Services industry.
What's Driving the Outperformance?
The stock has a great record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last four quarters. In its last earnings report on May 9, 2019, Cardlytics, Inc. reported EPS of $-0.23 versus consensus estimate of $-0.37 while it missed the consensus revenue estimate by 0.02%.
For the current fiscal year, Cardlytics, Inc. is expected to post earnings of $-0.6 per share on $186.97 million in revenues. This represents a 17.81% change in EPS on a 24.08% change in revenues. For the next fiscal year, the company is expected to earn $0.19 per share on $258.93 million in revenues. This represents a year-over-year change of 133% and 38.49%, respectively.
Valuation Metrics
Cardlytics, Inc. may be at a 52-week high right now, but what might the future hold for the stock? A key aspect of this question is taking a look at valuation metrics in order to determine if the company has run ahead of itself.
On this front, we can look at the Zacks Style Scores, as these give investors a variety of ways to comb through stocks (beyond looking at the Zacks Rank of a security). These styles are represented by grades running from A to F in the categories of Value, Growth, and Momentum, while there is a combined VGM Score as well. The idea behind the style scores is to help investors pick the most appropriate Zacks Rank stocks based on their individual investment style.
Cardlytics, Inc. has a Value Score of F. The stock's Growth and Momentum Scores are A and A, respectively, giving the company a VGM Score of B.
Zacks Rank
We also need to look at the Zacks Rank for the stock, as this supersedes any trend on the style score front. Fortunately, Cardlytics, Inc. currently has a Zacks Rank of #2 (Buy) thanks to favorable earnings estimate revisions from covering analysts.
Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Cardlytics, Inc. passes the test. Thus, it seems as though Cardlytics, Inc. shares could have a bit more room to run in the near term.
How Does Cardlytics, Inc. Stack Up to the Competition?
Shares of Cardlytics, Inc. have been moving higher, and the company still appears to be a decent choice, but what about the rest of the industry? Some of its industry peers are also solid potential picks, including Jianpu Technology , Smiths Group (SMGZY - Free Report) , and TeleTech Holdings (TTEC - Free Report) , all of which currently have a Zacks Rank of at least #2 and a VGM Score of at least B, making them well-rounded choices.
The Zacks Industry Rank is in the top 39% of all the industries we have in our universe, so it looks like there are some nice tailwinds for Cardlytics, Inc.even beyond its own solid fundamental situation.